您当前的位置：
首页 >
文章列表页 >
Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome
更新时间：2024-08-21

    • Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome

      增强出版
    • “The latest research has found that Yiqi Huoxue Formula can significantly improve the cardiac function of rats with coronary heart disease Qi deficiency and blood stasis syndrome by regulating the cAMP/Epac1/Rap1 signaling pathway, reducing blood viscosity and plasma cAMP content, and decreasing myocardial injury and collagen fiber proliferation.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 18, Pages: 107-116(2024)

    • DOI：10.13422/j.cnki.syfjx.20231819    

      CLC： R284.2;R285;R289;R287;R22;R2-031;R33;R24

    • Received：07 August 2023，

      Published Online：04 January 2024，

      Published：20 September 2024

    移动端阅览

  • WU Huaying,DENG Kai,LI Jing,et al.Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(18):107-116. DOI： 10.13422/j.cnki.syfjx.20231819.

  •  
  •  

0

Views

54

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Meaning， Efficacy and Mechanism of Huoxin Pills in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Correlations Between Severity of Heart Failure Related to Coronary Heart Disease of Qi Deficiency and Blood Stasis Syndrome and Biological Indexes
Mechanism of Yiqi Huoxue Decoction in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics

Related Author

YANG Xiu-juan
ZHU Rui-xuan
XIE Ran
YANG Lei
CHEN Jin-cheng
XU bao-xin
SHI Xiao-chun
WANG Peng-qian

Related Institution

Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
Youcare Pharmaceutical Group Co. Ltd.
Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
School of Clinical Medicine，Beijing University of Chinese Medicine
0